OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
300037$67.9358

Shenzhen Capchem Technology Co Ltd

Specialty ChemicalsVerified

Shenzhen Capchem Technology Co Ltd maintains a market capitalization of CNY 51.07 billion and a price-to-earnings ratio of 46.54, significantly above the median for the specialty chemicals industry. The company's price-to-book ratio of 4.73 suggests a premium valuation relative to its book value. Free cash flow for the period was CNY 302.46 million, while capital expenditures totaled CNY -972.45 million, indicating a net outflow of cash for investment. Profitability metrics show a return on equity of 10.16% and a return on assets of 5.54%, both below the industry median for specialty chemicals. The company's operating margin is 13.25% (CNY 1.28 billion operating income on CNY 9.64 billion revenue), and net margin is 11.38% (CNY 1.10 billion net income on CNY 9.64 billion revenue). These figures suggest moderate profitability relative to peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of segment or geographic diversification increases exposure to sector-specific and regional economic risks. Looking ahead, the company is projected to grow revenue by 12.5% in the current fiscal year and 8.2% in the next, based on analyst estimates and historical performance. However, the capital expenditure outflow of CNY 972.45 million suggests a focus on long-term capacity expansion rather than immediate profitability. The company faces moderate liquidity risk, with a current ratio of 1.72 and a debt-to-equity ratio of 0.24. While leverage is low, the negative net cash position after subtracting total debt raises concerns about short-term liquidity. The risk assessment also flags dilution as low, with no immediate pressure from share issuance or convertible debt. Recent investor relations data shows a mean price target of CNY 69.48, with a median of CNY 68.47. Analysts have issued five strong-buy and three buy ratings, indicating a generally positive outlook. However, the wide range of price targets (CNY 55.00 to CNY 86.00) reflects uncertainty in valuation expectations.

30-day price · 300037+11.42 (+20.7%)
Low$54.02High$72.86Close$66.53As of21 May, 00:00 UTC
Profile
CompanyShenzhen Capchem Technology Co Ltd
Ticker300037.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Shenzhen Capchem Technology Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Shenzhen Capchem Technology Co Ltd maintains a market capitalization of CNY 51.07 billion and a price-to-earnings ratio of 46.54, significantly above the median for the specialty chemicals industry. The company's price-to-book ratio of 4.73 suggests a premium valuation relative to its book value. Free cash flow for the period was CNY 302.46 million, while capital expenditures totaled CNY -972.45 million, indicating a net outflow of cash for investment. Profitability metrics show a return on equity of 10.16% and a return on assets of 5.54%, both below the industry median for specialty chemicals. The company's operating margin is 13.25% (CNY 1.28 billion operating income on CNY 9.64 billion revenue), and net margin is 11.38% (CNY 1.10 billion net income on CNY 9.64 billion revenue). These figures suggest moderate profitability relative to peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of segment or geographic diversification increases exposure to sector-specific and regional economic risks. Looking ahead, the company is projected to grow revenue by 12.5% in the current fiscal year and 8.2% in the next, based on analyst estimates and historical performance. However, the capital expenditure outflow of CNY 972.45 million suggests a focus on long-term capacity expansion rather than immediate profitability. The company faces moderate liquidity risk, with a current ratio of 1.72 and a debt-to-equity ratio of 0.24. While leverage is low, the negative net cash position after subtracting total debt raises concerns about short-term liquidity. The risk assessment also flags dilution as low, with no immediate pressure from share issuance or convertible debt. Recent investor relations data shows a mean price target of CNY 69.48, with a median of CNY 68.47. Analysts have issued five strong-buy and three buy ratings, indicating a generally positive outlook. However, the wide range of price targets (CNY 55.00 to CNY 86.00) reflects uncertainty in valuation expectations.
Key takeaways
  • The company trades at a premium valuation (P/E 46.54, P/B 4.73), suggesting high growth expectations.
  • Profitability metrics (ROE 10.16%, ROA 5.54%) are below industry medians, indicating room for improvement.
  • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • Analysts are generally optimistic, with a mean price target of CNY 69.48 and five strong-buy ratings.
  • The company is investing heavily in capital expenditures, which may impact short-term liquidity.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$9.64B
Gross profit$2.30B
Operating income$1.28B
Net income$1.10B
R&D
SG&A
D&A
SBC
Operating cash flow$1.17B
CapEx-$972.4M
Free cash flow$302.5M
Total assets$19.80B
Total liabilities$9.00B
Total equity$10.80B
Cash & equivalents
Long-term debt$2.55B
Valuation
Market price$67.93
Market cap$51.07B
Enterprise value$53.62B
P/E46.5
Reported non-GAAP P/E
EV/Revenue5.6
EV/Op income42.0
EV/OCF45.9
P/B4.7
P/Tangible book4.7
Tangible book$10.80B
Net cash-$2.55B
Current ratio1.7
Debt/Equity0.2
ROA5.5%
ROE10.2%
Cash conversion1.1%
CapEx/Revenue-10.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300037Activity
Op margin13.2%0.4% medp25 -8.0% · p75 16.0%above median
Net margin11.4%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin23.9%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-10.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity24.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target69.48 CNY
Median price target68.47 CNY
High price target86.00 CNY
Low price target55.00 CNY
Mean recommendation1.70 (1=strong buy, 5=strong sell)
Strong-buy count5.00
Buy count3.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate2.75 CNY
Last actual EPS1.43 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 01:08 UTCJob: 721a5ea4